Cite
Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
MLA
Van Hove, Johan L. K., et al. “Protein Biomarkers GDF15 and FGF21 to Differentiate Mitochondrial Hepatopathies from Other Pediatric Liver Diseases.” Hepatology Communications, vol. 8, no. 1, Jan. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.1097/HC9.0000000000000361.
APA
Van Hove, J. L. K., Friederich, M. W., Strode, D. K., Van Hove, R. A., Miller, K. R., Sharma, R., Shah, H., Estrella, J., Gabel, L., Horslen, S., Kohli, R., Lovell, M. A., Miethke, A. G., Molleston, J. P., Romero, R., Squires, J. E., Alonso, E. M., Guthery, S. L., Kamath, B. M., & Loomes, K. M. (2024). Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases. Hepatology Communications, 8(1), 1–16. https://doi.org/10.1097/HC9.0000000000000361
Chicago
Van Hove, Johan L. K., Marisa W. Friederich, Dana K. Strode, Roxanne A. Van Hove, Kristen R. Miller, Rohit Sharma, Hardik Shah, et al. 2024. “Protein Biomarkers GDF15 and FGF21 to Differentiate Mitochondrial Hepatopathies from Other Pediatric Liver Diseases.” Hepatology Communications 8 (1): 1–16. doi:10.1097/HC9.0000000000000361.